Please assess the completion status of the following clinical trial:

Trial Title: Near Normalisation of BG Improves the Potentiating Effect of GLP-1

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-70 years~* Type 2 diabetes diagnosed after 30 years of age~* BMI \> 25~Exclusion Criteria:~* Severe complications to diabetes~* Abnormal liver og kidney function~* Haemoglobin below the lower limit~* Macroalbuminuria~* Systemic disease~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- GLP-1 (Type: EXPERIMENTAL): A graded glucose infusion with an infusion of GLP-1 (1½ pmol/kg/min)
- Saline (Type: EXPERIMENTAL): A graded glucose infusion together with a continuous infusion of saline

Based on this trial design, predict the completion outcome and termination type (if applicable).